2,6-Diaminopurine | CAS:1904-98-9

We serve 2,6-Diaminopurine CAS:1904-98-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
2,6-Diaminopurine

Chemical Name:2,6-Diaminopurine
CAS.NO:1904-98-9
Synonyms:2,6-diamino purine
1H-Purine-2,6-diamine
2,6-Daminopurine
2-Aminoadenine
2,6-diamino-9H-purine
Molecular Formula:C5H6N6
Molecular Weight:150.14100
 
Physical and Chemical Properties:
Density:1.743;
Melting point:117-122ºC;
Boiling point:285ºC;
Flash point:155ºC;
Index of Refraction:2.109;
 
Specification:
Appearance:White to off-white crystalline powder
Assay(HPLC):≥99.0%
Loss on drying:≤0.5%
Residue on ignition:≤0.5%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Fluorodarabine intermediate.



Contact us for information like 2,6-diamino purine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2,6-diamino-9H-purine physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2,6-diamino-9H-purine Use and application,2,6-diamino-9H-purine technical grade,usp/ep/jp grade.


Related News: Russia, which shares a 2,600-mile border with China, reported its first two coronavirus cases on Friday.1-isothiocyanato-3,5-bis(trifluoromethyl)benzene manufacturer Russia, which shares a 2,600-mile border with China, reported its first two coronavirus cases on Friday.3-Morpholino-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one supplier INSPIRE is a global, multi-center, randomized, controlled study to assess the efficacy and safety of IV rigosertib in higher-risk MDS (HR-MDS) patients who had progressed on, failed to respond to, or relapsed after previous treatment with a hypomethylating agent (HMA) within nine cycles over the course of one year after initiation of HMA treatment.1-benzofuran-6-carboxylic acid vendor INSPIRE is a global, multi-center, randomized, controlled study to assess the efficacy and safety of IV rigosertib in higher-risk MDS (HR-MDS) patients who had progressed on, failed to respond to, or relapsed after previous treatment with a hypomethylating agent (HMA) within nine cycles over the course of one year after initiation of HMA treatment.Villages and cities in China have resorted to flying drones with speakers to patrol streets and scold people not wearing masks in public amid the coronavirus outbreak, according to Chinese state media.